All Stories

  1. Health Research and Education during and after the COVID-19 Pandemic: An Australian Clinician and Researcher Perspective

    Article • Diagnostics, January 2023, MDPI AG

    Prof Roy G Beran

  2. Use of Interval Therapy with Benzodiazepines to Prevent Seizure Recurrence in Stressful Situations

    Article • Brain Sciences, April 2022, MDPI AG

    Prof Roy G Beran

  3. Management and attitudes toward patients with epilepsy in general practice: How far have we come in three decades?

    Article • Epilepsy & Behavior, August 2019, Elsevier

    Prof Roy G Beran

  4. A decision tree to determine fitness to drive in epilepsy: Results of a pilot in two Australian states

    Article • Epilepsia, May 2019, Wiley

    Prof Roy G Beran

  5. Diagnostic Coding: A Novel Approach to Quality Assurance in Private Practice

    Article • Archives in Neurology & Neuroscience, February 2019, Iris Publishers LLC

    Prof Roy G Beran

  6. Commentary on “High incidence of persistent sub-therapeutic levels of most common AEDs in children with epilepsy receiving polypharmacy”

    Article • Epilepsy Research, December 2018, Elsevier

    Prof Roy G Beran

  7. Reflection on stroke deaths and end-of-life stroke care

    Article • Internal Medicine Journal, March 2018, Wiley

    Prof Roy G Beran

  8. Training and Expectations for the Expert Witness in Australia: Could Guidelines Work in the US?

    Article • Journal of Legal Medicine, December 2017, Taylor & Francis

    Prof Roy G Beran

  9. Can head trauma trigger adult-onset Rasmussen's encephalitis?

    Article • Epilepsy & Behavior, September 2017, Elsevier

    Prof Roy G Beran

  10. Medical certificates attesting fitness to drive

    Article • Internal Medicine Journal, June 2017, Wiley

    Prof Roy G Beran

  11. Legal imperatives in treating severe stroke

    Article • International Journal of Stroke, October 2016, SAGE Publications

    Prof Roy G Beran

  12. Fitness to drive — When all may not be as it seems

    Article • Epilepsy & Behavior, September 2016, Elsevier

    Prof Roy G Beran

  13. Mandatory reporting

    Article • The Medical Journal of Australia, September 2016, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Prof Roy G Beran

  14. Vertebral artery dissection in hypertensive disorders of pregnancy: a case series and literature review

    Article • BMC Pregnancy and Childbirth, July 2016, Springer Science + Business Media

    Prof Roy G Beran

  15. Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod

    Article • Drug Design Development and Therapy, June 2016, Dove Medical Press

    Dr Erwin Chiquete, Prof Roy G Beran, Nadina Frider

  16. Justification for conducting neurological clinical trials as part of patient care within private practice

    Article • International Journal of Clinical Practice, April 2016, Wiley

    Prof Roy G Beran

  17. Ibuprofen for the treatment of TTH

    Article • Evidence-Based Medicine, January 2016, BMJ

    Prof Roy G Beran

  18. Generic substitution in contravention of doctor's prescriptions

    Article • Internal Medicine Journal, October 2015, Wiley

    Prof Roy G Beran

  19. Nontraumatic spinal cord ischaemic syndrome

    Article • Journal of Clinical Neuroscience, October 2015, Elsevier

    Prof Roy G Beran

  20. The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study

    Article • International Journal of MS Care, May 2015, Consortium of Multiple Sclerosis Centers

    Prof Roy G Beran

  21. Author reply

    Article • Internal Medicine Journal, April 2015, Wiley

    Prof Roy G Beran

  22. SUDEP revisited – A decade on: Have circumstances changed?

    Article • Seizure, April 2015, Elsevier

    Prof Roy G Beran

  23. Sudden unexpected death in epilepsy

    Article • Epilepsy & Behavior, March 2015, Elsevier

    Prof Roy G Beran

  24. Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study

    Article • BMC Neurology, February 2015, Springer Science + Business Media

    Prof Roy G Beran

  25. Anti-synthetase syndrome associated with anti PL-12 and anti-Signal recognition particle antibodies and a necrotizing auto-immune myositis

    Article • Journal of Clinical Neuroscience, February 2015, Elsevier

    Prof Roy G Beran

  26. Importance of cardiological evaluation for first seizures

    Article • World Journal of Clinical Cases, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof Roy G Beran

  27. The benefits of antiepileptic drug (AED) blood level monitoring to complement clinical management of people with epilepsy

    Article • Epilepsy & Behavior, January 2015, Elsevier

    Prof Roy G Beran

  28. Mandatory notification of impaired doctors

    Article • Internal Medicine Journal, December 2014, Wiley

    Prof Roy G Beran

  29. An appraisal of the new operational definition of epilepsy—Then and now

    Article • Epilepsy & Behavior, December 2014, Elsevier

    Prof Roy G Beran

  30. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs)

    Article • Seizure, May 2014, Elsevier

    Prof Roy G Beran

  31. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

    Article • The Lancet Neurology, March 2014, Elsevier

    Prof Roy G Beran

  32. Rectal carbamazepine as effective long-acting treatment after cluster seizures and status epilepticus

    Article • Epilepsy & Behavior, February 2014, Elsevier

    Prof Roy G Beran

  33. Compulsive gambling possibly associated with antiepileptic medication

    Article • Epilepsy & Behavior Case Reports, January 2014, Elsevier

    Prof Roy G Beran

  34. Analysis of the latest Austroads guidelines for fitness to drive as promulgated in March 2012

    Article • Internal Medicine Journal, August 2013, Wiley

    Prof Roy G Beran

  35. Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population (2005–09)

    Article • Journal of Clinical Neuroscience, July 2013, Elsevier

    Prof Roy G Beran

  36. Rebound exacerbation multiple sclerosis following cessation of oral treatment

    Article • Multiple Sclerosis and Related Disorders, July 2013, Elsevier

    Prof Roy G Beran

  37. Sleep-disordered breathing in multiple sclerosis

    Article • Neurology, April 2013, Wolters Kluwer Health

    Prof Roy G Beran

  38. Heat stroke induced cerebellar dysfunction: A “forgotten syndrome”

    Article • World Journal of Clinical Cases, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof Roy G Beran

  39. Legal and Forensic Medicine

    Article • January 2013, Springer Science + Business Media

    Prof Roy G Beran

  40. Episodic Dyscontrol, Rage, and Violence

    Article • October 2012, Oxford University Press (OUP)

    Prof Roy G Beran

  41. Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis

    Article • Archives of Neurology, October 2012, American Medical Association (AMA)

    Dr. Ron Milo, Prof Roy G Beran

  42. Low positive predictive value of the ABCD2 score in emergency department transient ischaemic attack diagnoses: the South Western Sydney Transient Ischaemic Attack Study

    Article • Internal Medicine Journal, August 2012, Wiley

    Prof Roy G Beran

  43. Membership survey of the Australasian College of Legal Medicine: Quality assurance

    Article • Journal of Forensic and Legal Medicine, August 2012, Elsevier

    Prof Roy G Beran

  44. Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

    Article • The Lancet Neurology, May 2012, Elsevier

    Dr. Ron Milo, Prof Roy G Beran

  45. Changed constitution without change in brand name – The risk of generics in epilepsy

    Article • Epilepsy Research, February 2012, Elsevier

    Prof Roy G Beran

  46. Pharmaceutical excipients

    Article • Australian Prescriber, February 2012, Therapeutic Guidelines Limited

    Prof Roy G Beran

  47. The neurological diagnostic consultation

    Article • January 2012, Elsevier

    Prof Roy G Beran

  48. The neurological examination

    Article • January 2012, Elsevier

    Prof Roy G Beran

  49. The neurological examination

    Article • January 2012, Elsevier

    Prof Roy G Beran

  50. Vertigo

    Article • January 2012, Elsevier

    Prof Roy G Beran

  51. The neurological examination

    Article • January 2012, Elsevier

    Prof Roy G Beran

  52. Peripheral neuropathy

    Article • January 2012, Elsevier

    Prof Roy G Beran

  53. Non-organic neurological diseases

    Article • January 2012, Elsevier

    Prof Roy G Beran

  54. Dementia

    Article • January 2012, Elsevier

    Prof Roy G Beran

  55. Epilepsy

    Article • January 2012, Elsevier

    Prof Roy G Beran

  56. Headache

    Article • January 2012, Elsevier

    Prof Roy G Beran

  57. The neurology of sleep

    Article • January 2012, Elsevier

    Prof Roy G Beran

  58. Pain

    Article • January 2012, Elsevier

    Prof Roy G Beran

  59. Preface

    Article • January 2012, Elsevier

    Prof Roy G Beran

  60. Parkinson's disease

    Article • January 2012, Elsevier

    Prof Roy G Beran

  61. Multiple sclerosis

    Article • January 2012, Elsevier

    Prof Roy G Beran

  62. Muscles

    Article • January 2012, Elsevier

    Prof Roy G Beran

  63. Stroke

    Article • January 2012, Elsevier

    Prof Roy G Beran

  64. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

    Article • Neurology, October 2011, Wolters Kluwer Health

    Prof Roy G Beran

  65. ‘Prolactinoma: are dopamine agonists still first choice?’

    Article • Internal Medicine Journal, October 2011, Wiley

    Prof Roy G Beran

  66. Letters to the editor

    Article • The Journal of the Royal College of Physicians of Edinburgh, September 2011, SAGE Publications

    Prof Roy G Beran

  67. Epilepsy stigma: What do we know and where next?

    Article • Epilepsy & Behavior, September 2011, Elsevier

    Prof Roy G Beran

  68. Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study

    Article • The Lancet Neurology, June 2011, Elsevier

    Prof Roy G Beran

  69. The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

    Article • European Journal of Neurology, December 2010, Wiley

    Dr Cristina M Ramo-Tello, Prof Roy G Beran

  70. Levetiracetam in chronic daily headache: A double-blind, randomised placebo-controlled study

    Article • Cephalalgia, November 2010, SAGE Publications

    Prof Roy G Beran

  71. Glyphosate–surfactant herbicide-induced reversible encephalopathy

    Article • Journal of Clinical Neuroscience, November 2010, Elsevier

    Prof Roy G Beran

  72. What is legal medicine – Are legal and forensic medicine the same?

    Article • Journal of Forensic and Legal Medicine, April 2010, Elsevier

    Prof Roy G Beran

  73. A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2010, New England Journal of Medicine (NEJM/MMS)

    Dr. Ron Milo, Prof Roy G Beran

  74. Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2010, New England Journal of Medicine (NEJM/MMS)

    Prof Roy G Beran

  75. Epilepsy and the Law

    Article • January 2010, Springer Science + Business Media

    Prof Roy G Beran

  76. Validation of Emergency and Final Diagnosis Coding in Transient Ischemic Attack: South Western Sydney Transient Ischemic Attack Study

    Article • Neuroepidemiology, January 2010, Karger Publishers

    Prof Roy G Beran

  77. Decreasing presentations of seizures to emergency departments in a large Australian population

    Article • Epilepsy & Behavior, November 2009, Elsevier

    Prof Roy G Beran

  78. Strategies for developing sleep research

    Article • Sleep and Biological Rhythms, October 2009, Springer Science + Business Media

    Prof Roy G Beran

  79. Crossed cerebellar hyperperfusion on ictal FDG PET in astrocytoma

    Article • Journal of Clinical Neuroscience, April 2009, Elsevier

    Prof Roy G Beran

  80. Sleepiness in multiple sclerosis: A pilot study

    Article • Sleep and Biological Rhythms, October 2008, Springer Science + Business Media

    Prof Roy G Beran

  81. Value of therapeutic drug level monitoring and unbound (free) levels

    Article • Seizure, September 2008, Elsevier

    Prof Roy G Beran

  82. Epilepsy and law

    Article • Epilepsy & Behavior, May 2008, Elsevier

    Prof Roy G Beran

  83. An alternative perspective on the management of status epilepticus

    Article • Epilepsy & Behavior, April 2008, Elsevier

    Prof Roy G Beran

  84. Analysis – What is legal medicine?

    Article • Journal of Forensic and Legal Medicine, April 2008, Elsevier

    Prof Roy G Beran

  85. Medical aspects of fitness to drive. What do public hospital doctors know and think

    Article • Internal Medicine Journal, February 2008, Wiley

    Prof Roy G Beran

  86. Meningococcal meningitis and a negative cerebrospinal fluid: Case report and its medicolegal implications

    Article • Emergency Medicine Australasia, November 2007, Wiley

    Prof Roy G Beran

  87. Association between ulcerative colitis and multiple sclerosis

    Article • Internal Medicine Journal, September 2007, Wiley

    Prof Roy G Beran

  88. The teaching of legal medicine in Australasia

    Article • Journal of Forensic and Legal Medicine, July 2007, Elsevier

    Prof Roy G Beran

  89. Road not taken: lessons to be learned from Queen v. Gillett

    Article • Internal Medicine Journal, May 2007, Wiley

    Prof Roy G Beran

  90. Opinions, attitudes and practices of Australian neurologists with regard to epilepsy and driving

    Article • Internal Medicine Journal, March 2007, Wiley

    Prof Roy G Beran

  91. The ethics of excluding women who become pregnant while participating in clinical trials of anti-epileptic medications

    Article • Seizure, December 2006, Elsevier

    Prof Roy G Beran

  92. Transfer of Lamolrigine Into Breast Milk

    Article • Annals of Pharmacotherapy, July 2006, SAGE Publications

    Prof Roy G Beran

  93. SUDEP—to discuss or not discuss: that is the question

    Article • The Lancet Neurology, June 2006, Elsevier

    Prof Roy G Beran

  94. Seizure control and treatment in pregnancy

    Article • Neurology, February 2006, Wolters Kluwer Health

    Prof Roy G Beran

  95. Analysis and overview of the guidelines for assessing fitness to drive for commercial and private vehicle drivers

    Article • Internal Medicine Journal, May 2005, Wiley

    Prof Roy G Beran

  96. Efficacy and safety of levetiracetam 1000–3000mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study

    Article • Epilepsy Research, January 2005, Elsevier

    Prof Roy G Beran

  97. Clinical Trials and the Independence of Investigators

    Article • International Journal of Pharmaceutical Medicine, January 2005, Springer Science + Business Media

    Prof Roy G Beran

  98. Review of the legal obligations of the doctor to discuss Sudden Unexplained Death in Epilepsy (SUDEP)—a cohort controlled comparative cross-matched study in an outpatient epilepsy clinic

    Article • Seizure, October 2004, Elsevier

    Prof Roy G Beran

  99. A pilot study of compassionate use of Levetiracetam in patients with generalised epilepsy

    Article • Journal of Clinical Neuroscience, September 2004, Elsevier

    Prof Roy G Beran

  100. Cognitive decline with chronic meningitis secondary to a COX-2 inhibitor

    Article • Age and Ageing, April 2004, Oxford University Press (OUP)

    Prof Roy G Beran

  101. Gabapentin in the prophylaxis of chronic daily headache

    Article • Neurology, December 2003, Wolters Kluwer Health

    Prof Roy G Beran

  102. Cervical ependymoma presenting with brainstem and cerebellar signs: case report

    Article • Journal of Clinical Neuroscience, May 2003, Elsevier

    Prof Roy G Beran

  103. The absorption of gabapentin following high dose escalation

    Article • Seizure, January 2003, Elsevier

    Prof Roy G Beran

  104. Legal aspects of epilepsy

    Article • Seizure, June 2002, Elsevier

    Prof Roy G Beran

  105. ILAE Commission on the Burden of Epilepsy, Subcommission on the Economic Burden of Epilepsy: Final Report 1998–2001

    Article • Epilepsia, June 2002, Wiley

    Prof Roy G Beran

  106. Economics in Epilepsy Treatment Choices: Our Certain Fate?

    Article • Epilepsia, April 2002, Wiley

    Prof Roy G Beran

  107. AUStralian Study of Titration to Effect Profile of Safety (AUS‐STEPS): High‐Dose Gabapentin (Neurontin) in Partial Seizures

    Article • Epilepsia, October 2001, Wiley

    Prof Roy G Beran

  108. Pilot Study of Prevalence of Parkinson’s Disease in Australia

    Article • Neuroepidemiology, January 2001, Karger Publishers

    Prof Roy G Beran

  109. Conduct of Trials in Private Clinical Practice

    Article • Epilepsia, July 2000, Wiley

    Prof Roy G Beran

  110. Facial pain as a presenting feature of intracerebral haemorrhage

    Article • Journal of Clinical Neuroscience, July 2000, Elsevier

    Prof Roy G Beran

  111. Validating a screening questionnaire for parkinsonism in Australia

    Article • Journal of Neurology Neurosurgery & Psychiatry, July 2000, BMJ

    Prof Roy G Beran

  112. Economic Analysis of Epilepsy Care

    Article • Epilepsia, August 1999, Wiley

    Prof Roy G Beran

  113. Letters to the Editor

    Article • Epilepsia, August 1999, Wiley

    Prof Roy G Beran

  114. The Burden of Epilepsy for the Patient: The Intangible Costs

    Article • Epilepsia, August 1999, Wiley

    Prof Roy G Beran

  115. Vision for the Future

    Article • Epilepsia, August 1999, Wiley

    Prof Roy G Beran

  116. Safety and efficacy of vigabatrin and carbamazepine in ne wly diagnosed epilepsy: a multicentre randomised double-blind study

    Article • The Lancet, July 1999, Elsevier

    Prof Roy G Beran

  117. Interface of epilepsy and sleep disorders

    Article • Seizure, April 1999, Elsevier

    Prof Roy G Beran

  118. Confidentiality and the management of patients with epilepsy who fail to comply with doctor's advice not to drive: A survey of medical/legal opinions in Australia

    Article • Seizure, December 1998, Elsevier

    Prof Roy G Beran

  119. Double‐Blind, Placebo‐Controlled, Lamotrigine in Treatment‐Resistant Generalised Epilepsy

    Article • Epilepsia, December 1998, Wiley

    Prof Roy G Beran

  120. Aggressive Behaviour in Intellectually Challenged Patients with Epilepsy Treated with Lamotrigine

    Article • Epilepsia, March 1998, Wiley

    Prof Roy G Beran

  121. Final Report of the ILAE Commission on Economic Aspects of Epilepsy, 1994–1997

    Article • Epilepsia, December 1997, Wiley

    Prof Roy G Beran

  122. The use of CPAP in patients with refractory epilepsy

    Article • Seizure, August 1997, Elsevier

    Prof Roy G Beran

  123. Professional privilege, driving and epilepsy, the doctor's responsibility

    Article • Epilepsy Research, February 1997, Elsevier

    Prof Roy G Beran

  124. A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizures

    Article • Seizure, December 1996, Elsevier

    Prof Roy G Beran

  125. An appraisal of the clinical use of lamotrigine under the special access scheme

    Article • Journal of Clinical Neuroscience, July 1996, Elsevier

    Prof Roy G Beran

  126. Report of the International League Against Epilepsy Commission on Economic Aspects of Epilepsy

    Article • Epilepsia, May 1996, Wiley

    Prof Roy G Beran

  127. Melatonin Response in Active Epilepsy

    Article • Epilepsia, January 1995, Wiley

    Prof Roy G Beran

  128. Management and Attitudes of Epilepsy by a Group of Sydney General Practitioners

    Article • Epilepsia, November 1994, Wiley

    Prof Roy G Beran

  129. A simultaneous electrocardiogram is important when electroencephalography is used in the evaluation of loss of consciousness

    Article • Electroencephalography and Clinical Neurophysiology, March 1994, Elsevier

    Prof Roy G Beran

  130. Clinical Trials of Antiepileptic Drugs Performed in the Private Practice Setting

    Article • Epilepsia, January 1994, Wiley

    Prof Roy G Beran

  131. Automatisms—The Gulf Between Medicine and the Law

    Article • Australian Journal of Forensic Sciences, December 1993, Taylor & Francis

    Prof Roy G Beran

  132. Therapeutic recreation programmes for children with epilepsy

    Article • Seizure, September 1993, Elsevier

    Prof Roy G Beran

  133. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.

    Article • Journal of Neurology Neurosurgery & Psychiatry, May 1993, BMJ

    Prof Roy G Beran

  134. Cross‐Reactive Skin Eruption with Both Carbamazepine and Oxcarbazepine

    Article • Epilepsia, January 1993, Wiley

    Prof Roy G Beran

  135. Chromosome fragility in the Lennox‐Gastaut epilepsy syndrome

    Article • Journal of Intellectual Disability Research, October 1992, Wiley

    Prof Roy G Beran

  136. Brown‐Sequard Syndrome Following Chemotherapy and Radiotherapy in Breast Carcinoma—A Case Report

    Article • Journal of Medical Imaging and Radiation Oncology, May 1991, Wiley

    Prof Roy G Beran

  137. Doctors’ perspectives regarding the changes in the delivery of health care to people with developmental disabilities

    Article • Australia and New Zealand Journal of Developmental Disabilities, January 1990, Taylor & Francis

    Prof Roy G Beran

  138. The Role of Computed Tomography in the Assessment of Neurologic Sequelae of Decompression Sickness

    Article • Archives of Neurology, September 1988, American Medical Association (AMA)

    Prof Roy G Beran

  139. PLASMA CONCENTRATIONS OF UNBOUND VALPROATE IN THE MANAGEMENT OF EPILEPSY

    Article • Australian and New Zealand Journal of Medicine, August 1988, Wiley

    Prof Roy G Beran

  140. Psychosocial Sequelae of Epilepsy: The Role of Associated Cerebral Pathology

    Article • Epilepsia, April 1987, Wiley

    Prof Roy G Beran

  141. An Accurate Assessment of the Prevalence Ratio of Epilepsy Adequately Adjusted by Influencing Factors

    Article • Neuroepidemiology, January 1985, Karger Publishers

    Prof Roy G Beran

  142. False-Negative Response Rate in Epidemiologic Studies to Define Prevalence Ratios of Epilepsy

    Article • Neuroepidemiology, January 1985, Karger Publishers

    Prof Roy G Beran

  143. A Survey of Doctors in Sydney, Australia: Perspectives and Practices Regarding Epilepsy and Those Affected by It

    Article • Epilepsia, February 1983, Wiley

    Prof Roy G Beran

  144. Population Prevalence of Epilepsy in Sydney, Australia

    Article • Neuroepidemiology, January 1982, Karger Publishers

    Prof Roy G Beran

  145. Dealing with epileptics

    Article • BMJ, September 1981, BMJ

    Prof Roy G Beran

  146. Doctors' Perspectives of Epilepsy

    Article • Epilepsia, August 1981, Wiley

    Prof Roy G Beran

  147. Myoclonus in Down's Syndrome

    Article • Archives of Neurology, July 1981, American Medical Association (AMA)

    Prof Roy G Beran

  148. Individualized Patient Assessment in the Treatment of Epilepsy with Sodium Valproate

    Article • Epilepsia, August 1980, Wiley

    Prof Roy G Beran

  149. Rectal administration of sodium valproate in status epilepticus

    Article • Neurology, March 1980, Wolters Kluwer Health

    Prof Roy G Beran

  150. Pharmacokinetics of sodium valproate in epileptic patients: Prediction of maintenance dosage by single-dose study

    Article • European Journal of Clinical Pharmacology, January 1980, Springer Science + Business Media

    Prof Roy G Beran